The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells
Kayoko Kibata,1 Tomoki Ito,1 Muneo Inaba,1 Akihiro Tanaka,1 Ryoichi Iwata,2 Noriko Inagaki-Katashiba,1 Vien Phan,1 Atsushi Satake,1 Shosaku Nomura11Kansai Medical University, First Department of Internal Medicine, Osaka, Japan; 2Kansai Medical University, Department of Neurosurgery, Osaka, JapanBack...
Main Authors: | Kibata K, Ito T, Inaba M, Tanaka A, Iwata R, Inagaki-Katashiba N, Phan V, Satake A, Nomura S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/the-immunomodulatory-drug-lenalidomide-sustains-and-enhances-interfero-peer-reviewed-article-JBM |
Similar Items
-
Immunomodulatory Compounds (Imids®) in the Treatment of Multiple Myeloma
by: Gordan Srkalovic, et al.
Published: (2009-10-01) -
Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them
by: Marco Cippitelli, et al.
Published: (2021-01-01) -
Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives
by: Piotr Kulig, et al.
Published: (2023-02-01) -
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study
by: Damian Mikulski, et al.
Published: (2022-10-01) -
Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy
by: Matteo Costacurta, et al.
Published: (2021-11-01)